Home » Topics » BioWorld Science

BioWorld Science
RSS

Orion completes OB-004 lead optimization

Dec. 3, 2021

GAT-564, a novel CB1R allosteric modulator with efficacy in murine model of glaucoma

Dec. 3, 2021

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

HCN targeting rescues chronic stress-induced cognitive deficits

Dec. 3, 2021

Wnt/beta-catenin pathway blocker C644-0303 inhibits colorectal cancer growth

Dec. 3, 2021

DREADD approach calms neuropsychiatric dread circuits in primates

Dec. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...